These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 12849125)

  • 1. Neural transplantation for the treatment of Parkinson's disease.
    Björklund A; Dunnett SB; Brundin P; Stoessl AJ; Freed CR; Breeze RE; Levivier M; Peschanski M; Studer L; Barker R
    Lancet Neurol; 2003 Jul; 2(7):437-45. PubMed ID: 12849125
    [No Abstract]   [Full Text] [Related]  

  • 2. Neural transplantation (auto-adrenal, fetal nigral and fetal adrenal) in Parkinson's disease: the Mexican experience.
    Madrazo I; Franco-Bourland R; Ostrosky-Solis F; Aguilera M; Cuevas C; Alvarez F; Magallon E; Zamorano C; Morelos A
    Prog Brain Res; 1990; 82():593-602. PubMed ID: 1981281
    [No Abstract]   [Full Text] [Related]  

  • 3. How to improve the survival of the fetal ventral mesencephalic cell transplanted in Parkinson's disease?
    Liu J; Huang HY
    Neurosci Bull; 2007 Nov; 23(6):377-82. PubMed ID: 18064069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefits and risks of hosting animal cells in the human brain.
    Isacson O; Breakefield XO
    Nat Med; 1997 Sep; 3(9):964-9. PubMed ID: 9288721
    [No Abstract]   [Full Text] [Related]  

  • 5. [Transplantation of embryonal nerve tissues in the treatment of Parkinson disease].
    Bekhtereva NP; Gilerovich EG; Gurchin FA; Lukin VA; Matveeva TS; Otellin VA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(11):10-3. PubMed ID: 1963958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Graft-induced dyskinesias fail to respond to 5HT1A agonist in the long-term.
    Beaulieu-Boire I; Fasano A
    Mov Disord; 2015 May; 30(6):872-3. PubMed ID: 25758209
    [No Abstract]   [Full Text] [Related]  

  • 7. Dyskinesias after transplantation in Parkinson's disease.
    Piccini P
    Lancet Neurol; 2002 Dec; 1(8):472. PubMed ID: 12849327
    [No Abstract]   [Full Text] [Related]  

  • 8. Practical aspects of the use of human fetal brain tissue for intracerebral grafting.
    Brundin P; Björklund A; Lindvall O
    Prog Brain Res; 1990; 82():707-14. PubMed ID: 2290974
    [No Abstract]   [Full Text] [Related]  

  • 9. Cellular replacement therapy for Parkinson's disease--where we are today?
    Redmond DE
    Neuroscientist; 2002 Oct; 8(5):457-88. PubMed ID: 12374430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transplantation therapy for Parkinson's disease.
    Borlongan CV
    Expert Opin Investig Drugs; 2000 Oct; 9(10):2319-30. PubMed ID: 11060809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereotactic implantation of fetal mesencephalon.
    Hitchcock ER; Kenny BG; Clough CG; Hughes RC; Henderson BT; Detta A
    Stereotact Funct Neurosurg; 1990; 54-55():282-9. PubMed ID: 2080343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parkinson's transplant therapy faces setback.
    Check E
    Nature; 2003 Aug; 424(6952):987. PubMed ID: 12944933
    [No Abstract]   [Full Text] [Related]  

  • 13. Grafting of fetal dopamine neurons in Parkinson's disease. The Czech experience with severe akinetic patients.
    Subrt O; Tichy M; Vladyka V; Hurt K
    Acta Neurochir Suppl (Wien); 1991; 52():51-3. PubMed ID: 1792967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regression of parkinsonian fetal ventral mesencephalon grafts upon withdrawal of cyclosporine A immunosuppression. The CPH Neural Transplantation Group.
    Lopez-Lozano JJ; Bravo G; Brera B; Dargallo J; Salmean J; Uria J; Insausti J; Martinez R; Sanchez P; de la Torre C; Moreno R
    Transplant Proc; 1997; 29(1-2):977-80. PubMed ID: 9123614
    [No Abstract]   [Full Text] [Related]  

  • 15. Neural transplantation in Parkinson's disease: the Swedish experience.
    Lindvall O; Rehncrona S; Brundin P; Gustavii B; Astedt B; Widner H; Lindholm T; Björklund A; Leenders KL; Rothwell JC
    Prog Brain Res; 1990; 82():729-34. PubMed ID: 2290977
    [No Abstract]   [Full Text] [Related]  

  • 16. Transplants in Parkinson's disease.
    Lindvall O
    Eur Neurol; 1991; 31 Suppl 1():17-27. PubMed ID: 1855521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased cell suspension concentration augments the survival rate of grafted tyrosine hydroxylase immunoreactive neurons.
    Terpstra BT; Collier TJ; Marchionini DM; Levine ND; Paumier KL; Sortwell CE
    J Neurosci Methods; 2007 Oct; 166(1):13-9. PubMed ID: 17706789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethical challenges in cell-based interventions for neurological conditions: some lessons to be learnt from clinical transplantation trials in patients with Parkinson's disease.
    Hildt E
    Am J Bioeth; 2009 May; 9(5):37-8. PubMed ID: 19396682
    [No Abstract]   [Full Text] [Related]  

  • 19. Cell therapy for Parkinson's disease.
    Fischbach GD; McKhann GM
    N Engl J Med; 2001 Mar; 344(10):763-5. PubMed ID: 11236783
    [No Abstract]   [Full Text] [Related]  

  • 20. The clinical application of cell grafting techniques in patients with Parkinson's disease.
    Quinn NP
    Prog Brain Res; 1990; 82():619-25. PubMed ID: 2290963
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.